đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
This study evaluates the safety and immunogenicity of the BPZE1 live attenu...
Status
Completed
Location
Rapid medical Research Inc
Start Date
2019-06-15
Trial ID
NCT03942406
Treatments Being Tested
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
This study evaluates the safety and immunogenicity of the BPZE1 live, atten...
Status
Completed
Location
Sydney Children's Hospital
Start Date
2021-11-11
Trial ID
NCT05116241
Treatments Being Tested
This study will evaluate the tolerability and immunogenicity of administrat...
Status
Completed
Location
Multiple Locations
Start Date
2009-10-21
Trial ID
NCT00988884
This study will evaluate the immunogenicity and safety of the pertussis com...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT01003431
The study is being conducted to demonstrate that the vaccine to prevent gas...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00258154
Treatments Being Tested
This two-stage study evaluates the immunogenicity, safety, and tolerability...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00289913
Treatments Being Tested
This study will evaluate the safety and tolerability and immunogenicity of ...
Status
Completed
Location
Queensland Children s Hospital ( Site 0004)
Start Date
2019-09-04
Trial ID
NCT04031846
Treatments Being Tested
Data from this study are expected to demonstrate that V501 (Human Papilloma...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00325130